Brief: Thomas A. Fitzgerald Reports 5.5% Stake In Transcode Therapeutics As Of June 14- SEC Filing
21/06/2024 21:07
Transcode Therapeutics Inc RNAZ.O :
* THOMAS A. FITZGERALD REPORTS 5.5% STAKE IN TRANSCODE
THERAPEUTICS AS OF JUNE 14- SEC FILING
Source text for Eikon: ID:n0001104659-24-073909
Further company coverage: RNAZ.O
Recent news on Transcode Therapeutics
See all newsBrief: TransCode Therapeutics Appoints John Tattory As Interim CFO
Brief: Transcode Therapeutics Appoints Dr. Anna Moore As Chair Of Scientific Advisory Board
Brief: Transcode Therapeutics Inc - Enters Exclusive License Agreement With Unleash
Brief: Transcode Therapeutics Ttx-Mc138 Phase 2A Clinical Trial Expected In First Half Of 2026
Brief: Transcode Therapeutics Expands Leadership With Appointment Of Jack E. Stover To Board Of Directors